Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Mar 20  •  04:00PM ET
4.94
Dollar change
-0.07
Percentage change
-1.40
%
Index- P/E- EPS (ttm)-0.07 Insider Own83.54% Shs Outstand194.17M Perf Week10.76%
Market Cap960.12M Forward P/E- EPS next Y- Insider Trans0.81% Shs Float32.00M Perf Month12.27%
Enterprise Value965.34M PEG- EPS next Q- Inst Own0.45% Short Float0.78% Perf Quarter-15.84%
Income-12.13M P/S22.64 EPS this Y- Inst Trans- Short Ratio2.55 Perf Half Y-9.19%
Sales42.41M P/B25.10 EPS next Y- ROA-20.77% Short Interest0.25M Perf YTD-13.03%
Book/sh0.20 P/C105.05 EPS next 5Y- ROE-46.94% 52W High22.42 -77.97% Perf Year-47.45%
Cash/sh0.05 P/FCF- EPS past 3/5Y36.64% 33.24% ROIC-29.90% 52W Low3.02 63.85% Perf 3Y-41.18%
Dividend Est.- EV/EBITDA- Sales past 3/5Y209.10% - Gross Margin43.38% Volatility6.61% 9.37% Perf 5Y-50.60%
Dividend TTM- EV/Sales22.76 EPS Y/Y TTM42.02% Oper. Margin-19.85% ATR (14)0.47 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.21 Sales Y/Y TTM105.78% Profit Margin-28.59% RSI (14)53.15 Recom-
Dividend Gr. 3/5Y- - Current Ratio1.86 EPS Q/Q-13.39% SMA203.37% Beta-132.73 Target Price-
Payout- Debt/Eq0.38 Sales Q/Q79.37% SMA504.92% Rel Volume0.61 Prev Close5.01
Employees483 LT Debt/Eq0.06 Earnings- SMA200-17.81% Avg Volume97.67K Price4.94
IPOOct 17, 2018 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume59,418 Change-1.40%
Mar-18-26 08:30AM
Mar-10-26 08:30AM
02:48AM
Mar-09-26 08:30AM
Jan-13-26 08:30AM
05:00PM Loading…
Jan-08-26 05:00PM
Jan-06-26 08:30AM
Dec-08-25 08:30AM
Nov-15-25 02:00PM
Nov-06-25 08:30AM
Oct-28-25 04:30PM
Oct-21-25 08:30AM
Oct-09-25 06:30AM
Oct-02-25 08:30AM
Oct-01-25 01:40PM
10:59AM Loading…
Sep-26-25 10:59AM
08:30AM
Sep-22-25 05:00AM
Sep-16-25 08:30AM
Sep-09-25 08:30AM
Aug-07-25 08:45AM
Jul-22-25 08:45AM
Jul-16-25 11:41AM
Jul-15-25 08:45AM
Jul-10-25 08:45AM
Jun-17-25 06:00AM
Jun-16-25 08:45AM
Jun-02-25 08:30AM
May-27-25 08:30AM
May-14-25 04:32PM
SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. Its proprietary software integrates Artificial Intelligence (AI) and Deep Learning, or machine learning (DL). It focuses on research and development to an AI-enhanced robotics platform system that can be combined with proven medical devices, end-effectors, and surgical instruments. The company was founded by Barry F. Cohen on February 4, 2015 and is headquartered in Fort Lauderdale, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOLL FREDERIC HDirectorMar 06 '26Buy3.99501,2531,999,99910,775,485Mar 10 06:05 PM
Adams Timothy P.DirectorMar 06 '26Buy3.99300,0001,197,0005,331,902Mar 10 06:04 PM
Sudhir SrivastavaChairman and CEOMar 06 '26Buy4.01498,7532,000,000109,851,767Mar 10 06:03 PM
Last Close
Mar 20  •  04:00PM ET
25.79
Dollar change
+0.11
Percentage change
0.43
%
PRCT Procept BioRobotics Corp daily Stock Chart
IndexRUT P/E- EPS (ttm)-1.72 Insider Own3.70% Shs Outstand56.32M Perf Week-4.94%
Market Cap1.45B Forward P/E- EPS next Y-0.90 Insider Trans23.94% Shs Float54.30M Perf Month-3.62%
Enterprise Value1.25B PEG- EPS next Q-0.55 Inst Own101.98% Short Float11.76% Perf Quarter-23.65%
Income-95.57M P/S4.72 EPS this Y10.76% Inst Trans-1.85% Short Ratio4.01 Perf Half Y-32.19%
Sales308.05M P/B3.97 EPS next Y41.10% ROA-18.34% Short Interest6.39M Perf YTD-18.02%
Book/sh6.50 P/C5.08 EPS next 5Y41.68% ROE-24.89% 52W High66.85 -61.42% Perf Year-55.43%
Cash/sh5.08 P/FCF- EPS past 3/5Y4.30% -7.02% ROIC-21.62% 52W Low19.35 33.28% Perf 3Y-19.61%
Dividend Est.- EV/EBITDA- Sales past 3/5Y60.14% 109.04% Gross Margin62.66% Volatility5.06% 8.42% Perf 5Y-
Dividend TTM- EV/Sales4.05 EPS Y/Y TTM2.21% Oper. Margin-33.71% ATR (14)1.95 Perf 10Y-
Dividend Ex-Date- Quick Ratio5.77 Sales Y/Y TTM37.22% Profit Margin-31.02% RSI (14)46.10 Recom1.73
Dividend Gr. 3/5Y- - Current Ratio6.85 EPS Q/Q-52.00% SMA20-0.91% Beta0.94 Target Price32.92
Payout- Debt/Eq0.21 Sales Q/Q11.94% SMA50-8.44% Rel Volume0.76 Prev Close25.68
Employees888 LT Debt/Eq0.21 EarningsFeb 25 AMC SMA200-32.79% Avg Volume1.59M Price25.79
IPOSep 15, 2021 Option/ShortYes / Yes EPS/Sales Surpr.-63.58% -18.54% Trades Volume1,219,480 Change0.43%
Date Action Analyst Rating Change Price Target Change
Mar-06-26Initiated Robert W. Baird Neutral $30
Feb-26-26Downgrade Oppenheimer Outperform → Perform
Feb-26-26Downgrade BofA Securities Neutral → Underperform $20
Dec-12-25Initiated UBS Buy $62
Dec-08-25Downgrade BofA Securities Buy → Neutral $38
Sep-02-25Upgrade Oppenheimer Perform → Outperform $60
Jul-09-25Initiated Stephens Overweight $70
Jul-07-25Initiated Oppenheimer Perform
Dec-02-24Initiated Morgan Stanley Overweight $105
Nov-14-24Initiated Jefferies Hold $95
Mar-16-26 12:27AM
Mar-12-26 09:00AM
Mar-03-26 08:18AM
Mar-01-26 11:35AM
Feb-26-26 04:34PM
04:06PM Loading…
04:06PM
11:21AM
10:17AM
08:30AM
07:55AM
07:04AM
02:11AM
12:04AM
Feb-25-26 07:25PM
04:02PM
10:20AM Loading…
Feb-24-26 10:20AM
Feb-23-26 04:03PM
07:23AM
Feb-12-26 08:09AM
Feb-05-26 08:15AM
Feb-04-26 05:40PM
04:03PM
Jan-26-26 04:03PM
Jan-08-26 09:12AM
Jan-07-26 08:41AM
Dec-22-25 06:50AM
Dec-15-25 07:03AM
Nov-20-25 04:03PM
Nov-18-25 05:07AM
Nov-05-25 12:04AM
05:40PM Loading…
Nov-04-25 05:40PM
04:03PM
Oct-30-25 10:00AM
Oct-29-25 09:00AM
Oct-28-25 10:00AM
Oct-20-25 11:08PM
09:20AM
Oct-15-25 04:03PM
Sep-15-25 09:01AM
Sep-04-25 06:13AM
Aug-27-25 08:29AM
Aug-21-25 12:30PM
11:15AM
Aug-13-25 12:08PM
Aug-06-25 05:45PM
04:03PM
Aug-05-25 08:15AM
Aug-04-25 05:45PM
Jul-31-25 10:30AM
Jul-30-25 10:00AM
Jul-25-25 07:00AM
Jul-24-25 06:00PM
Jul-23-25 08:00AM
Jul-21-25 04:03PM
Jul-14-25 09:15PM
Apr-29-25 04:03PM
Apr-24-25 04:03PM
02:37PM
08:15AM
07:00AM
Apr-10-25 04:03PM
Mar-29-25 06:03PM
Mar-24-25 08:00AM
Mar-20-25 09:05AM
Mar-14-25 08:00AM
Feb-26-25 09:32AM
02:15AM
Feb-25-25 05:25PM
04:02PM
01:22AM
Feb-13-25 02:10PM
Feb-07-25 08:00AM
Jan-16-25 12:00PM
Dec-28-24 04:59AM
Nov-29-24 11:15AM
Nov-26-24 04:05PM
Nov-07-24 12:00PM
Nov-01-24 02:27PM
Oct-29-24 08:43PM
12:00PM
11:56AM
03:03AM
Oct-28-24 05:41PM
04:19PM
02:17PM
11:39AM
08:10AM
07:00AM
07:00AM
Oct-25-24 09:35AM
09:01AM
Oct-21-24 10:00AM
Oct-09-24 04:04PM
Oct-08-24 12:29PM
Oct-07-24 04:04PM
Oct-05-24 06:04PM
Sep-25-24 09:01AM
Sep-23-24 09:03AM
Aug-30-24 05:57AM
Aug-28-24 04:03PM
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nouri AlalehEVP, CLO, CORP. SEC.Mar 19 '26Sale25.965,363139,231105,354Mar 19 05:47 PM
Alalah NouriOfficerMar 19 '26Proposed Sale26.175,363140,349Mar 19 04:57 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 17 '26Sale28.153048,559110,717Mar 19 04:25 PM
Waters KevinEVP, CFOMar 17 '26Sale28.1570619,876151,558Mar 19 04:25 PM
Nouri AlalehOfficerMar 17 '26Proposed Sale28.153048,559Mar 17 03:14 PM
Waters KevinOfficerMar 17 '26Proposed Sale28.1570619,876Mar 17 03:13 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 10 '26Sale25.653,24383,197111,021Mar 12 04:02 PM
Alalah NouriOfficerMar 10 '26Proposed Sale25.263,24381,918Mar 10 04:04 PM
Desai Antal RohitDirectorMar 05 '26Buy25.58167,2464,278,549167,246Mar 09 07:19 PM
Desai Antal RohitDirectorMar 06 '26Buy23.59160,3173,781,503327,563Mar 09 07:19 PM
Desai Antal RohitDirectorMar 09 '26Buy24.5598,6992,422,891426,262Mar 09 07:19 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 06 '26Sale23.706,892163,353114,264Mar 09 05:43 PM
Waters KevinEVP, CFOMar 06 '26Sale23.706,721159,300152,264Mar 09 05:40 PM
Nouri AlalehOfficerMar 06 '26Proposed Sale23.706,892163,353Mar 06 04:19 PM
Waters KevinOfficerMar 06 '26Proposed Sale23.706,721159,300Mar 06 04:07 PM
Desai Antal RohitDirectorAug 14 '25Option Exercise1.3326,74935,57635,152Aug 15 04:53 PM
MOLL FREDERIC HDirectorAug 13 '25Buy39.2620,000785,138863,159Aug 14 04:18 PM
Nouri AlalehEVP, CLO, CORP. SEC.Aug 14 '25Option Exercise4.5211,00049,72072,473Aug 14 04:15 PM
Desai Antal RohitDirectorJun 10 '25Sale63.9125,0001,597,71164,363Jun 12 07:28 PM
Desai Antal RohitDirectorJun 11 '25Sale63.3825,0001,584,52539,363Jun 12 07:28 PM
Desai Antal RohitDirectorJun 12 '25Sale61.4925,0001,537,25614,363Jun 12 07:28 PM
SHAM SHIBLAQOfficerJun 06 '25Proposed Sale64.1320,0001,282,638Jun 06 04:22 PM
Shiblaq HishamEVP, Chief Comm. OfficerJun 06 '25Option Exercise5.1820,000103,60083,133Jun 06 04:02 PM
Shiblaq HishamEVP, Chief Comm. OfficerJun 06 '25Sale64.1320,0001,282,63763,133Jun 06 04:02 PM
Desai Antal RohitDirectorJun 05 '25Sale64.7925,0001,619,83089,363Jun 05 08:05 PM
Desai Antal RohitDirectorJun 04 '25Sale61.0225,0001,525,556114,363Jun 05 08:05 PM
Desai Antal RohitDirectorJun 03 '25Sale60.6625,0001,516,475139,363Jun 05 08:05 PM
222 DNA TRUST DirectorJun 03 '25Proposed Sale57.94150,0008,691,000Jun 03 04:24 PM
Zadno RezaPresident, CEOMay 09 '25Option Exercise7.2713,759100,028186,829May 13 04:59 PM